Page last updated: 2024-10-27

foscarnet and Cardiovascular Diseases

foscarnet has been researched along with Cardiovascular Diseases in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giachelli, CM1
Jono, S1
Shioi, A1
Nishizawa, Y1
Mori, K1
Morii, H1

Reviews

1 review available for foscarnet and Cardiovascular Diseases

ArticleYear
Vascular calcification and inorganic phosphate.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 1

    Topics: Actins; Animals; Calcinosis; Cardiovascular Diseases; Carrier Proteins; Cells, Cultured; Dose-Respon

2001